These Guidelines are based upon the best information available at the time of publication. They are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management.
Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health-care professional making use of these Guidelines is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation.
The recommendations for research contained within this document are general and do not imply a specific protocol.
In citing this document, the following format should be used:
National Kidney Foundation. KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42:S1-S202, 2003 (suppl 3)
These Guidelines, as well as other KDOQI guidelines, can be accessed on the internet at: www.kdoqi.org
The development of the KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease is supported by an unrestricted educational grant from Abbott Renal Care.
Additional support was received from Amgen Inc. and Genzyme Therapeutics.
|
|
The National Kidney Foundation gratefully acknowledges the support of Amgen Inc., founding and principal sponsor of KDOQI.
